Text of KY HB 501 (2025)
AN ACT relating to pharmaceutical drugs.
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
1,315 characters
UNOFFICIAL COPY
25 RS BR 1362
Page 1 of 1
XXXX 2/6/2025 3:32 PM
Jacketed
AN ACT relating to the practice of pharmacy.
1
Be it enacted by the General Assembly of the Commonwealth of Kentucky:
2
SECTION 1. A NEW SECTION OF KRS CHAPTER 315 IS CREATED TO
3
READ AS FOLLOWS:
4
(1)
Notwithstanding any other provision of law to the contrary, when a pharmacist is
5
aware that a practitioner has died, a prescription issued by that practitioner may
6
continue to be dispensed based on the pharmacist's professional judgment and in
7
accordance with the following requirements:
8
(a)
A new prescription that has not been previously dispensed may be dispensed
9
no later than ninety (90) days following the date on which the practitioner
10
died; and
11
(b)
A prescription that has been previously dispensed and has valid
12
authorization to be refilled may be dispensed no later than one hundred
13
eighty (180) days following the date on which the practitioner died.
14
(2)
Nothing in this section authorizes the dispensing of a prescription that was issued
15
for a controlled substance unless permitted under the federal Controlled
16
Substances Act and regulations of the United States Drug Enforcement
17
Administration.
18
As enrolled or final
1,757 characters
CHAPTER 161
Legislative Research Commission PDF Version
1
CHAPTER 161
( HB 501 )
AN ACT relating to pharmaceutical drugs.
Be it enacted by the General Assembly of the Commonwealth of Kentucky:
SECTION 1. A NEW SECTION OF KRS CHAPTER 315 IS CREATED TO READ AS FOLLOWS:
(1)
Notwithstanding any other provision of law to the contrary, when a pharmacist is aware that a practitioner
has died, a prescription issued by that practitioner may continue to be dispensed based on the pharmacist's
professional judgment and no later than one hundred eighty (180) days following the date on which the
practitioner died.
(2)
Nothing in this section authorizes the dispensing of a prescription that was issued for a controlled
substance unless permitted under the federal Controlled Substances Act and regulations of the United
States Drug Enforcement Administration.
Section 2. 2025 RS HB 495/VO, Section 1, is amended to read as follows:
Notwithstanding any provision of law to the contrary and unless required under federal law, the Department for
Medicaid Services and any managed care organization with whom the department contracts for the delivery of
Medicaid services are hereby prohibited from expending any Medicaid funds on any of the following:
(1)
Cross-sex hormones when prescribed or administered primarily or solely for the treatment of gender
dysphoria[in amounts greater than would normally be produced endogenously in a healthy person of the same
age and sex]; and
(2)
Gender reassignment surgery to alter or remove physical or anatomical characteristics or features that are
typical for and characteristic of a person's biological sex.
Became law without Governor's signature April 10, 2025.